Blood Cell Storage, Inc. (BCSI)
BCSI is an international medical device company based in Seattle, Washington, with European operations based in The Netherlands. BCSI exists for a simple reason: To create value for all stake holders (patients, clinicians, collaborators and shareholders) by leveraging our fluorescent dye, microfluidics, and Nucleic Acid Extraction capabilities and Intellectual Property to reduce healthcare costs AND improve patient outcomes.
BCSI's initial product is a closed-loop pH monitoring system for platelets introduced in 2007 to the blood bank industry in Europe. BCSI’s products are unique in that they do not violate the sterility of the platelet storage bag, a critical limitation of current products, and can be used anywhere along the blood collection/ distribution chain.
The photo is of BCSI's pH1000TM, the world's first non-invasive monitoring system for platelets.
Learn more about the pH1000 system.
|
BCSI's second product is a flat-glass card for nucleic acid isolation. It is capable of quickly, easily, and reliably isolating nucleic acids (DNA and RNA) from blood and a variety of other biological samples.
Patent Pending. Learn more... |
Pure Nucleic Acid, Hassle Free |
